187 related articles for article (PubMed ID: 7657385)
1. Analysis of the GAP-related domain of the neurofibromatosis type 1 (NF1) gene in childhood brain tumors.
Scheurlen WG; Senf L
Int J Cancer; 1995 Aug; 64(4):234-8. PubMed ID: 7657385
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation.
Nishi T; Lee PS; Oka K; Levin VA; Tanase S; Morino Y; Saya H
Oncogene; 1991 Sep; 6(9):1555-9. PubMed ID: 1923522
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutations in the neurofibromatosis 1 gene in human tumors.
Li Y; Bollag G; Clark R; Stevens J; Conroy L; Fults D; Ward K; Friedman E; Samowitz W; Robertson M
Cell; 1992 Apr; 69(2):275-81. PubMed ID: 1568247
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing of neurofibromatosis type 1 gene transcript in malignant brain tumors: PCR analysis of frozen-section mRNA.
Mochizuki H; Nishi T; Bruner JM; Lee PS; Levin VA; Saya H
Mol Carcinog; 1992; 6(2):83-7. PubMed ID: 1388685
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis type 1 (NF1) gene: implication in neuroectodermal differentiation and genesis of brain tumors.
Nishi T; Saya H
Cancer Metastasis Rev; 1991 Dec; 10(4):301-10. PubMed ID: 1786631
[TBL] [Abstract][Full Text] [Related]
6. Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene.
Upadhyaya M; Osborn MJ; Maynard J; Kim MR; Tamanoi F; Cooper DN
Hum Genet; 1997 Jan; 99(1):88-92. PubMed ID: 9003501
[TBL] [Abstract][Full Text] [Related]
7. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity.
Andersen LB; Ballester R; Marchuk DA; Chang E; Gutmann DH; Saulino AM; Camonis J; Wigler M; Collins FS
Mol Cell Biol; 1993 Jan; 13(1):487-95. PubMed ID: 8417346
[TBL] [Abstract][Full Text] [Related]
8. Analysis of mutations and expression of GAP-related domain of the neurofibromatosis type 1 (NF1) gene in the progression of chronic myelogenous leukemia.
Nakai H; Misawa S; Horiike S; Taniwaki M; Seriu T; Shimazaki C; Fujii H; Maekawa T; Furukawa T; Abe T
Leukemia; 1994 Jun; 8(6):1027-33. PubMed ID: 8207976
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras.
Yunoue S; Tokuo H; Fukunaga K; Feng L; Ozawa T; Nishi T; Kikuchi A; Hattori S; Kuratsu J; Saya H; Araki N
J Biol Chem; 2003 Jul; 278(29):26958-69. PubMed ID: 12730209
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia.
Garicochea B; Giorgi R; Odone VF; Dorlhiac-Llacer PE; Bendit I
Leuk Res; 1998 Nov; 22(11):1003-7. PubMed ID: 9783802
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of the neurofibromatosis type 1 protein product.
DeClue JE; Cohen BD; Lowy DR
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9914-8. PubMed ID: 1946460
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations in the neurofibromatosis 1 gene in gliomas and primitive neuroectodermal tumours.
Thiel G; Marczinek K; Neumann R; Witkowski R; Marchuk DA; Nurnberg P
Anticancer Res; 1995; 15(6B):2495-9. PubMed ID: 8669813
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of RASK and the 'FLR exon' of NF1 in sporadic ovarian carcinoma.
Foulkes WD; Englefield P; Campbell IG
Eur J Cancer; 1994; 30A(4):528-30. PubMed ID: 8018414
[TBL] [Abstract][Full Text] [Related]
14. Expression of two types of neurofibromatosis type 1 gene transcripts in gastric cancers and comparison of GAP activities.
Uchida T; Matozaki T; Suzuki T; Matsuda K; Wada K; Nakano O; Konda Y; Nishisaki H; Nagao M; Sakamoto C
Biochem Biophys Res Commun; 1992 Aug; 187(1):332-9. PubMed ID: 1520317
[TBL] [Abstract][Full Text] [Related]
15. Multiple transcripts of the neurofibromatosis type 1 gene in human brain and in brain tumours.
Takahashi K; Suzuki H; Kayama T; Suzuki Y; Yoshimoto T; Sasano H; Shibahara S
Clin Sci (Lond); 1994 Nov; 87(5):481-5. PubMed ID: 7874833
[TBL] [Abstract][Full Text] [Related]
16. A novel isoform of the neurofibromatosis type-1 mRNA and a switch of isoforms during murine cell differentiation and proliferation.
Mantani A; Wakasugi S; Yokota Y; Abe K; Ushio Y; Yamamura K
Gene; 1994 Oct; 148(2):245-51. PubMed ID: 7958951
[TBL] [Abstract][Full Text] [Related]
17. The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype.
Nur-E-Kamal MS; Varga M; Maruta H
J Biol Chem; 1993 Oct; 268(30):22331-7. PubMed ID: 8226742
[TBL] [Abstract][Full Text] [Related]
18. The two types of mRNAs for neurofibromin isoforms produced by von Recklinghausen neurofibromatosis (NF1) gene: analysis in human astrocytic tumors.
Tokuyama T; Uemura K; Fujita M
Neurosci Lett; 1995 Aug; 196(3):189-92. PubMed ID: 7501280
[TBL] [Abstract][Full Text] [Related]
19. Brain tumors predominantly express the neurofibromatosis type 1 gene transcripts containing the 63 base insert in the region coding for GTPase activating protein-related domain.
Suzuki Y; Suzuki H; Kayama T; Yoshimoto T; Shibahara S
Biochem Biophys Res Commun; 1991 Dec; 181(3):955-61. PubMed ID: 1662505
[TBL] [Abstract][Full Text] [Related]
20. Suppression of oncogenic Ras by mutant neurofibromatosis type 1 genes with single amino acid substitutions.
Nakafuku M; Nagamine M; Ohtoshi A; Tanaka K; Toh-e A; Kaziro Y
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6706-10. PubMed ID: 8341688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
